Karve, Shrirang
Translate Bio (United States)
5 papers on CoChatORCID 0000-0002-9433-3089
Most cited papers
- Verified
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system
DeRosa, F., Guild, B., Karve, S., Smith, L., Love, K., Dorkin, J. R., Kauffman, K. J., Zhang, J., Yahalom, B., Anderson, D. G., et al. (2016) · Gene Therapy
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 159
- Verified
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
Chivukula, S., Plitnik, T., Tibbitts, T., Karve, S., Dias, A., Zhang, D., Goldman, R., Gopani, H., Khanmohammed, A., Sarode, A., et al. (2021) · npj Vaccines
Influenza Virus Research StudiesRNA Interference and Gene Delivery
Cited by 117
- Verified
Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity
Sethi, M., Sukumar, R., Karve, S., Werner, M. E., Wang, E. C., Moore, D. T., Kowalczyk, S. R., Zhang, L., & Wang, A. Z. (2014) · Nanoscale
Nanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery
Cited by 102
- Verified
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
Kalnin, K. V., Plitnik, T., Kishko, M., Zhang, J., Zhang, D., Beauvais, A., Anosova, N. G., Tibbitts, T., DiNapoli, J., Ulinski, G., et al. (2021) · npj Vaccines
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 82
- Verified
Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates
Kalnin, K. V., Plitnik, T., Kishko, M., Zhang, J., Zhang, D., Beauvais, A., Anosova, N. G., Tibbitts, T., DiNapoli, J. M., Huang, P.-W. D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory)
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free